Health Condition 1: K508- Crohns disease of both small andlarge intestine Health Condition 2: K519- Ulcerative colitis, unspecified
Conditions
Interventions
Intervention1: Placebo group:: Patients will be on their regular diet for 12 weeks
Intervention2: Experimental group: Patients will receive FUBR three servings per day in addition to their regular die
Sponsors
MINISTRY OF HEALTH AND FAMILY WELFARE
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Those who have given consent 2) Male or female patients aged above 12 years 3) Confirmed diagnosis of IBD
Exclusion criteria
Exclusion criteria: 1) Those who have not given consent 2) Patients less than 12 years 3) Patients with severe form of IBD like Toxic colitis 4) Patients with severe co-morbid illness like Cardiac illness, Pulmonary problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome: â?? Clinical response as per Harvey-Bradshaw Index for Crohnâ??s disease and Partial Mayo Scoring Index {Time Frame: 0 and 12 weeks) Timepoint: 0 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Endoscopic remission as per Crohns disease Endoscopic Index of Severity and Ulcerative colitis Endoscopic Index of Severity Reduction Stoppage of IBD medicines Change in patient Quality of life Change in Short Inflammatory Bowel Disease questionnaire Response to each questions is graded from 1 to 7 Changes in Inflammatory marker Changes in Gut microbiome profile Timepoint: 12 WEEKS | — |
Countries
India
Contacts
Public ContactJESWANTH SATYANESAN
GOVT STANLEY MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed